SLIDESHOW

Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth

Sat, Jul 06, 2013 at 16:12

| Source: Moneycontrol.com
Share   .   Email   .   Print      

Aurobindo Pharma

Q1FY14 Profit (estimates): Rs 182 crore

YoY jump (estimates): 130.4%

Target: Rs 271

Rating: BUY

Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.